ImmunologybioRxiv
ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy
I. Dutta, D. Dieters-Castator, J. W. Papatzimas…·G. M. Siegers
This study identifies ADAM protease inhibition as a strategy to overcome resistance of breast cancer stem-like cells to γδ T cell immunotherapy by blocking MICA shedding.
DOI 10.1016/j.canlet.2020.10.013